UNH Stock Recent News

UNH has been sold off, thanks to the market's overreaction to the FQ4'24 top-line miss and mixed FY2025 guidance, as medical costs continue to grow. Despite headwinds, robust growth in Optum Rx and OptumHealth segments may balance UnitedHealthcare challenges, supporting the management's ambitious FY2025 targets. The consensus downgrades and UNH's discounted valuations highlight the market's pessimism, with it presenting a contrarian Buy opportunity.

Here are some of the major companies whose stocks moved on the week's news.

UnitedHealth breezes past the Zacks Consensus Estimate for earnings but misses the same for revenues.

UnitedHealth Group (NYSE: UNH) recently reported its Q4 results, with revenues missing and earnings exceeding the street expectations. The company reported revenue of $100.8 billion and adjusted earnings of $6.81 per share, compared to the consensus estimates of $101.8 billion and $6.72, respectively.

UnitedHealth Group (UNH) shares fell sharply Thursday after the health insurer reported fourth-quarter results below Wall Street's expectations and issued a lackluster outlook amid higher medical costs.

Major U.S. equities indexes ticked lower on Thursday, failing to gain ground a day after soft inflation data and an upbeat start to earnings season helped drive a strong rally.

Shares of UnitedHealth Group (UNH -4.86%) were pulling back Thursday after the company delivered underwhelming fourth-quarter results, as sales were weaker than expected and its costs rose.

Shares in the insurance provider dropped after the firm disclosed its first earnings report since the shocking assassination of Brian Thompson, its insurance branch's chief executive.

UNH projects revenues between $450 billion and $455 billion for 2025.

UnitedHealth Group Incorporated (NYSE:UNH ) Q4 2024 Earnings Conference Call January 16, 2025 8:45 AM ET Company Participants Andrew Witty - Chief Executive Officer John Rex - Chief Financial Officer Amar Desai - Chief Executive Officer, Optum Health Tim Noel - Chief Executive Officer, UnitedHealthcare Medicare & Retirement Bobby Hunter - President, Medicare Sandeep Dadlani - Chief Technology Officer Conference Call Participants A.J. Rice - UBS Josh Raskin - Nephron Lisa Gill - JPMorgan Stephen Baxter - Wells Fargo Justin Lake - Wolfe Research Lance Wilkes - Bernstein David Windley - Jefferies Scott Fidel - Stephens Sarah James - Cantor Fitzgerald Joanna Gajuk - Bank of America Operator Good morning, and welcome to UnitedHealth Group Fourth Quarter and Full Year 2024 Earnings Conference Call.